Albers Andreas E, Visus Carmen, Tsukishiro Takashi, Ferris Robert L, Gooding William, Whiteside Theresa L, De Leo Albert B
Division of Basic Research and Biostatistics, University of Pittsburgh Cancer Institute and Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Clin Cancer Res. 2006 Apr 15;12(8):2394-403. doi: 10.1158/1078-0432.CCR-05-1818.
Apoptosis of activated CD8(+) T cells is often seen in tumor-infiltrating lymphocytes and circulating peripheral blood mononuclear cells (PBMC) in patients with squamous cell carcinoma of the head and neck (SCCHN). We investigated whether T-cell receptor (TCR) variable beta chain (Vbeta)-restricted T cells were more sensitive to apoptosis than non-TCR Vbeta-restricted T cells.
Flow cytometry analysis with anti-TCR Vbeta antibodies was used to define expansions and contractions of Vbeta-restricted T cells in patients with SCCHN relative to normal donors. This staining was combined with Annexin V binding to indicate early T-cell apoptosis.
The TCR Vbeta profiles of CD3(+) T cells in tumor-infiltrating lymphocytes and PBMCs of patients with SCCHN were altered relative to controls, with one to five expansions and numerous contractions of TCR Vbeta-restricted T cells detected. These types of alterations were significantly greater in CD8(+) than CD4(+) T cells. Enhanced Annexin V binding to CD8(+) T cells was evident in PBMCs obtained from all patients, with 3 of 13 showing preferential targeting for apoptosis of TCR Vbeta-restricted T cells.
TCR Vbeta profiles of CD8(+) T cells were altered in patients with SCCHN relative to normal controls. This may reflect increased apoptosis of expanded or contracted CD8(+) T cells, which define the TCR Vbeta profile of antigen-responsive T-cell populations in patients with cancer.
在头颈部鳞状细胞癌(SCCHN)患者的肿瘤浸润淋巴细胞和循环外周血单个核细胞(PBMC)中,常可见活化的CD8(+) T细胞发生凋亡。我们研究了T细胞受体(TCR)可变β链(Vβ)限制性T细胞是否比非TCR Vβ限制性T细胞对凋亡更敏感。
使用抗TCR Vβ抗体进行流式细胞术分析,以确定SCCHN患者相对于正常供体的Vβ限制性T细胞的扩增和收缩情况。这种染色与膜联蛋白V结合以指示早期T细胞凋亡。
相对于对照组,SCCHN患者肿瘤浸润淋巴细胞和PBMC中CD3(+) T细胞的TCR Vβ谱发生改变,检测到TCR Vβ限制性T细胞有1至5次扩增和大量收缩。这些类型的改变在CD8(+) T细胞中比在CD4(+) T细胞中明显更大。在所有患者获得的PBMC中,膜联蛋白V与CD8(+) T细胞的结合增强,13例中有3例显示TCR Vβ限制性T细胞优先发生凋亡。
相对于正常对照,SCCHN患者CD8(+) T细胞的TCR Vβ谱发生改变。这可能反映了扩增或收缩的CD8(+) T细胞凋亡增加,这些细胞定义了癌症患者中抗原反应性T细胞群体的TCR Vβ谱。